Literature DB >> 34240263

Aptamers isolated against mosquito-borne pathogens.

Tholasi Nadhan Navien1, Tzi Shien Yeoh1, Andrew Anna1,2, Thean-Hock Tang3, Marimuthu Citartan4.   

Abstract

Mosquito-borne diseases are a major threat to public health. The shortcomings of diagnostic tools, especially those that are antibody-based, have been blamed in part for the rising annual morbidity and mortality caused by these diseases. Antibodies harbor a number of disadvantages that can be clearly addressed by aptamers as the more promising molecular recognition elements. Aptamers are defined as single-stranded DNA or RNA oligonucleotides generated by SELEX that exhibit high binding affinity and specificity against a wide variety of target molecules based on their unique structural conformations. A number of aptamers were developed against mosquito-borne pathogens such as Dengue virus, Zika virus, Chikungunya virus, Plasmodium parasite, Francisella tularensis, Japanese encephalitis virus, Venezuelan equine encephalitis virus, Rift Valley fever virus and Yellow fever virus. Intrigued by these achievements, we carry out a comprehensive overview of the aptamers developed against these mosquito-borne infectious agents. Characteristics of the aptamers and their roles in diagnostic, therapeutic as well as other applications are emphasized.

Entities:  

Keywords:  Aptamer; Disease; Mosquito; Pathogen; SELEX

Year:  2021        PMID: 34240263     DOI: 10.1007/s11274-021-03097-0

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  134 in total

1.  Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors:  Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 2.  Rift Valley fever virus.

Authors:  Brian H Bird; Thomas G Ksiazek; Stuart T Nichol; N James Maclachlan
Journal:  J Am Vet Med Assoc       Date:  2009-04-01       Impact factor: 1.936

3.  A new immunoassay of hybrid nanomater conjugated to aptamers for the detection of dengue virus.

Authors:  Caroline R Basso; Bruno P Crulhas; Massimiliano Magro; Fabio Vianello; Valber A Pedrosa
Journal:  Talanta       Date:  2019-01-17       Impact factor: 6.057

4.  Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus.

Authors:  Brian H Bird; Darcy A Bawiec; Thomas G Ksiazek; Trevor R Shoemaker; Stuart T Nichol
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

5.  Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens.

Authors:  G W Anderson; J F Saluzzo; T G Ksiazek; J F Smith; W Ennis; D Thureen; C J Peters; J P Digoutte
Journal:  Res Virol       Date:  1989 Mar-Apr

Review 6.  Malaria.

Authors:  Elizabeth A Ashley; Aung Pyae Phyo; Charles J Woodrow
Journal:  Lancet       Date:  2018-04-06       Impact factor: 79.321

Review 7.  Recent developments in vaccines and biological therapies against Japanese encephalitis virus.

Authors:  Luisa Barzon; Giorgio Palù
Journal:  Expert Opin Biol Ther       Date:  2018-07-19       Impact factor: 4.388

8.  Transmission of tularemia from a water source by transstadial maintenance in a mosquito vector.

Authors:  Stina Bäckman; Jonas Näslund; Mats Forsman; Johanna Thelaus
Journal:  Sci Rep       Date:  2015-01-22       Impact factor: 4.379

9.  In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Anders Barfod; Tina Persson; Johan Lindh
Journal:  Parasitol Res       Date:  2009-08-20       Impact factor: 2.289

10.  A need to raise the bar - A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research.

Authors:  Tehmina Bharucha; Freya M Shearer; Manivanh Vongsouvath; Mayfong Mayxay; Xavier de Lamballerie; Paul N Newton; Nicole Zitzmann; Ernest Gould; Audrey Dubot-Pérès
Journal:  Int J Infect Dis       Date:  2020-03-20       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.